|
Hinchliffe A, Kogevinas M, Molina AJ, Moreno V, Aragones N, Castano-Vinyals G, Jimenez Moleon JJ, Gomez Acebo I, Ederra M, Amiano P, Molina-Barcelo A, Fernandez-Tardon G, Alguacil J, Chirlaque MD, Hernandez-Segura N, Perez-Gomez B, Pollan M, Turner MC. Association of occupational heat exposure and colorectal cancer in the MCC-Spain study. Scand J Work Environ Health. 2023 Apr 1;49(3):211-221. doi: 10.5271/sjweh.4082. Epub 2023 Feb 19. PubMed PMID: 36807489; PubMed Central PMCID: PMC10621896.
AÑO: 2023; IF: 4.7
|
36807489
|
Castello A, Rodriguez-Barranco M, Perez-Gomez B, Chirlaque MD, Bonet C, Amiano P, Ardanaz E, Huerta JM, Zamora-Ros R, Quiros JR, Barricarte-Gurrea A, Pollan M, Sanchez MJ. High adherence to Western dietary pattern and prostate cancer risk: findings from the EPIC-Spain cohort. BJU Int. 2023 Sep;132(3):272-282. doi: 10.1111/bju.16001. Epub 2023 Apr 19. PubMed PMID: 37073612.
AÑO: 2023; IF: 3.7
|
|
Fontvieille E, Viallon V, Recalde M, Cordova R, Jansana A, Peruchet-Noray L, Lennon H, Heath AK, Aune D, Christakoudi S, Katzke V, Kaaks R, Inan-Eroglu E, Schulze MB, Mellemkjaer L, Tjonneland A, Overvad K, Farras M, Petrova D, Amiano P, Chirlaque MD, Moreno-Iribas C, Tin Tin S, Masala G, Sieri S, Ricceri F, Panico S, May AM, Monninkhof EM, Weiderpass E, Gunter MJ, Ferrari P, Freisling H. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 2023 Nov 23;21(1):418. doi: 10.1186/s12916-023-03114-z. PubMed PMID: 37993940; PubMed Central PMCID: PMC10666332.
AÑO: 2023; IF: 7.0
|
|
Castro-Espin C, Bonet C, Crous-Bou M, Katzke V, Le Cornet C, Jannasch F, Schulze MB, Olsen A, Tjonneland A, Dahm CC, Antoniussen CS, Sanchez MJ, Amiano P, Chirlaque MD, Guevara M, Agnoli C, Tumino R, Sacerdote C, De Magistris MS, Sund M, Boden S, Jensen TE, Olsen KS, Skeie G, Gunter MJ, Rinaldi S, Gonzalez-Gil EM, Weiderpass E, Christakoudi S, Heath AK, Dossus L, Agudo A. Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study. Br J Cancer. 2023 Mar;128(7):1301-1310. doi: 10.1038/s41416-023-02169-2. Epub 2023 Feb 3. PubMed PMID: 36737658; PubMed Central PMCID: PMC10050013.
AÑO: 2023; IF: 6.4
|
|
Allione A, Viberti C, Cotellessa I, Catalano C, Casalone E, Cugliari G, Russo A, Guarrera S, Mirabelli D, Sacerdote C, Gentile M, Eichelmann F, Schulze MB, Harlid S, Eriksen AK, Tjonneland A, Andersson M, Dolle MET, Van Puyvelde H, Weiderpass E, Rodriguez-Barranco M, Agudo A, Heath AK, Chirlaque MD, Truong T, Dragic D, Severi G, Sieri S, Sandanger TM, Ardanaz E, Vineis P, Matullo G. Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort. Int J Cancer. 2023 Feb 15;152(4):725-737. doi: 10.1002/ijc.34339. Epub 2022 Nov 5. PubMed PMID: 36305648.
AÑO: 2023; IF: 5.7
|